China Biologic Products, Inc. (CBPO)

[surf1944]

3 Oversold Biotech Stocks Undervalued By Levered Free Cash Flow

2. China Biologic Products, Inc. (CBPO): Engages in the research, development, manufacturing, and sale of plasma-based pharmaceutical products. Market cap of $173.99M. RSI(14) at 37.14. Levered free cash flow/enterprise value at 15.16% (levered free cash flow at $17.88M and enterprise value at $117.96M). The stock is a short squeeze candidate, with a short float at 6.28% (equivalent to 44.65 days of average volume). The stock is currently stuck in a downtrend, trading 11.78% below its SMA20, 20.2% below its SMA50, and 47.87% below its SMA200. It's been a rough couple of days for the stock, losing 11.1% over the last week.

http://seekingalpha.com/article/296333-3-oversold-biotech-stocks-undervalued-by-levered-free-cash-flow?source=yahoo